Lingyan Xu

Title: Lingyan Xu: Innovator in Non-Steroidal Anti-Inflammatory Medicaments

Introduction

Lingyan Xu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory medicaments. His innovative work focuses on improving the efficacy and safety of these medications.

Latest Patents

Lingyan Xu holds a patent for "Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same." This invention involves the design and synthesis of ascorbyl ester derivatives of aryl (ethanoic) propanoic acid, which includes well-known medications such as ibuprofen, ketoprofen, and naproxen. The patent highlights the remarkable antipyretic and analgesic effects of these derivatives, making them suitable for various age groups, including infants and the elderly. The invention also addresses the improvement of water solubility, facilitating intravenous administration and enhancing bioavailability while reducing gastrointestinal stimulation.

Career Highlights

Throughout his career, Lingyan Xu has worked with Wuxi Hongrui Bio-Pharma-Tech Co., Ltd. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in medication safety and effectiveness.

Collaborations

Lingyan Xu has collaborated with notable colleagues, including Luhong Tang and Ajuan Dai, who have contributed to his research and development efforts in the pharmaceutical field.

Conclusion

Lingyan Xu's innovative work in the development of non-steroidal anti-inflammatory medicaments showcases his commitment to improving healthcare solutions. His contributions have the potential to enhance the quality of life for many individuals.